| USD millions | FY2021 | FY2023 | FY2024 | FY2024 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | — | — | — | 0.0 | 0.1 | 0.0 | 0.0 | — | |
| Gross profit | — | — | — | (0.0) | (0.1) | 0.0 | 0.0 | — | |
| Research & development | 26.1 | 27.2 | 13.0 | 3.6 | 3.0 | 4.9 | — | — | |
| Operating expenses | 30.2 | 32.9 | 17.7 | 7.5 | 6.3 | 8.5 | — | — | |
| Operating income | (30.2) | — | — | (7.5) | (6.3) | (8.5) | (10.0) | −17.0% | |
| Interest expense | — | — | — | 0.0 | 0.0 | 0.0 | — | — | |
| Pre-tax income | (28.8) | (32.5) | 17.9 | 6.9 | 7.5 | (10.3) | (11.3) | −10.0% | |
| Income tax | 0.0 | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (28.8) | (32.5) | (17.9) | (6.9) | (7.5) | (10.3) | (11.3) | −10.0% | |
| EPS, basic (per share) | 1.35 | 19.80 | 127.80 | 30.00 | 8.08 | 2.39 | (4.98) | −308.6% | |
| EPS, diluted (per share) | — | 19.80 | 127.80 | 30.00 | 8.08 | 2.39 | (4.98) | −308.6% | |
| EBITDA | (30.2) | — | — | (7.5) | (6.2) | (8.5) | — | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | — | — | — | |
| Weighted average shares (shares) | — | 1,639,843 | 139,682 | 230,795 | 930,822 | 4,311,323 | — | — | |
| Weighted average diluted shares (shares) | 21,280,787 | 1,639,843 | 139,682 | 230,795 | 930,822 | 4,311,323 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
